Latest in News & Research

Twelve-Week Treatment Regimen Reduces Facial Redness

Skin seemed less inflamed, improvement seen in overall skin appearance, and skin looked and felt healthier
By Physician’s Briefing Staff | | July 01, 2022

What Factors Are Associated With the Burden of Atopic Dermatitis?

Atopic dermatitis severity and time spent managing symptoms have the strongest associations with disease burden
By Dermsquared Editorial Team | | June 29, 2022

Is Mohs Micrographic Surgery Beneficial for High-Risk cSCC?

Mohs yields high five-year disease specific survival, local recurrence-free survival, and regional/distant metastasis-free survival
By Dermsquared Editorial Team | | June 29, 2022

Experts Address Lab Monitoring of Isotretinoin for Treating Acne

Consensus reached on recommendations to test alanine aminotransferase, triglycerides within a month prior to initiation and at peak dose
By Physician’s Briefing Staff | | June 29, 2022

Should Secukinumab Dosing for Psoriasis Be Adjusted for Patient Weight?

PASI 90 responses significantly higher for secukinumab 300 mg every two weeks versus every four weeks for patients weighing ≥90 kg
By Dermsquared Editorial Team | | June 22, 2022

Two Patient-Reported Outcome Measures Useful for Determining QoL With Acne

Systematic review finds that Acne-Q and CompAQ can be used for measuring acne-associated quality of life
By Dermsquared Editorial Team | | June 22, 2022

Prevalence of Metabolic Syndrome 32 Percent in Psoriasis Patients

Patients with psoriasis vulgaris or severe psoriasis had higher prevalence of MetS compared with other types
By Physician’s Briefing Staff | | June 22, 2022

Tiny Mites Are Feeding on Your Skin, But for How Long?

Survey shows lack of knowledge may lead to behaviors that contribute to sun damage, skin cancer
By Dennis Thompson (HealthDay News) | | June 22, 2022

Predictors of Diagnostic Delay in Psoriasis Identified

Male patients have longer diagnostic delay than female patients; longer diagnostic delay seen for those with psoriasis in specific areas
By Physician’s Briefing Staff | | June 21, 2022

Study Compares Baricitinib to Dexamethasone for COVID-19

Baricitinib plus remdesivir shows similar efficacy but better safety profile than dexamethasone plus remdesivir in hospitalized adults
By Physician’s Briefing Staff | | June 21, 2022

Skin Tags? Moles? Products Promising to Treat Them Can Do Real Harm

By Cara Murez (HealthDay News) | | June 20, 2022

Diffuse Reflectance Spectroscopy Can Help Assess Psoriasis Severity

Mexameter erythema readings are a good representation of skin oxygenated hemoglobin, but not deoxygenated hemoglobin
By Physician's Briefing Staff | | June 16, 2022

Immediate, Delayed Reactions to Fragrances ID'd in Thai Population

Cinnamic aldehyde and cinnamic alcohol were most frequently encountered substances in immediate, delayed reactions
By Dermsquared Editorial Team | | June 15, 2022

Lichen Sclerosus Linked to Depression, Anxiety in Adult Women

Lichen sclerosus remained significantly associated with depression and anxiety in multivariable analyses
By Dermsquared Editorial Team | | June 15, 2022

Global Seroprevalence of Tickborne Lyme Disease About 14.5 Percent

Factors associated with Bb seropositivity include male sex, age ≥50 years, residence in rural areas, suffering tick bites
By Physician's Briefing Staff | | June 14, 2022

FDA Approves First Pill to Treat Severe Alopecia Areata

Olumiant is the first FDA-approved alopecia therapy that treats the entire body rather than a specific spot
By Physician’s Briefing Staff | | June 14, 2022

Higher Fish Intake May Increase Melanoma Risk

Higher total fish intake, tuna intake, nonfried fish intake positively linked to risks of malignant melanoma, melanoma in situ
By Physician's Briefing Staff | | June 10, 2022

Tretinoin Precursors, Tretinoin Work Similarly for Facial Photodamage

MMP2 mRNA was significantly reduced in TTP-treated samples; changes in MMP2 were associated with changes in fine wrinkles
By Dermsquared Editorial Team | | June 08, 2022

Alopecia Areata Symptom Impact Scale Tied to Disease Severity, Response

Alopecia Areata Quality of Life Index showed no correlation with AA severity pretreatment or posttreatment
By Dermsquared Editorial Team | | June 08, 2022

Lotion, Cream, Gel, and Ointment Similarly Effective for Childhood Eczema

Patient choice and personal preferences should guide selection decisions
By Physician's Briefing Staff | | June 02, 2022

Do Personal Care Products Contribute to Frontal Fibrosing Alopecia?

Link seen for sunscreen and facial moisturizer; no link seen for facial cleanser, hair products, cosmetic foundation
By Dermsquared Editorial Team | | June 01, 2022

Can Reflectance Confocal Microscopy Reduce Unnecessary Excisions?

Adjunctive RCM associated with higher positive predictive value, lower benign-to-malignant ratio compared with standard therapeutic care alone
By Dermsquared Editorial Team | | June 01, 2022

Psoriasis Tied to Higher Risk for Nonalcoholic Fatty Liver Disease

Authors say this association may be relevant to psoriasis management with some antipsoriatic agents
By Physician’s Briefing Staff | | June 01, 2022

24 of 1200

Headline from the Week of February 09 - 15, 2026

Second Annual National Cancer Database Report Presented for 2022

By Elana Gotkine (HealthDay News) | | February 11, 2026

Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma

By Elana Gotkine (HealthDay News) | | February 11, 2026